149 related articles for article (PubMed ID: 3270515)
1. Correlation between lung cancer prevalence and activities of aryl hydrocarbon hydroxylase and glutathione S-transferase in human lung tissues.
Liu L; Wang LH
Biomed Environ Sci; 1988 Oct; 1(3):277-82. PubMed ID: 3270515
[TBL] [Abstract][Full Text] [Related]
2. Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients.
Petruzzelli S; Camus AM; Carrozzi L; Ghelarducci L; Rindi M; Menconi G; Angeletti CA; Ahotupa M; Hietanen E; Aitio A
Cancer Res; 1988 Aug; 48(16):4695-700. PubMed ID: 3135117
[TBL] [Abstract][Full Text] [Related]
3. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer.
Nakajima T; Elovaara E; Anttila S; Hirvonen A; Camus AM; Hayes JD; Ketterer B; Vainio H
Carcinogenesis; 1995 Apr; 16(4):707-11. PubMed ID: 7728947
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon hydroxylase activity in human lung tissue: in relation to cigarette smoking and lung cancer.
Yoshikawa M; Arashidani K; Kawamoto T; Kodama Y
Environ Res; 1994 Apr; 65(1):1-11. PubMed ID: 8162876
[TBL] [Abstract][Full Text] [Related]
5. The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population.
Kiyohara C; Nakanishi Y; Inutsuka S; Takayama K; Hara N; Motohiro A; Tanaka K; Kono S; Hirohata T
Pharmacogenetics; 1998 Aug; 8(4):315-23. PubMed ID: 9731718
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controls.
Kärki NT; Pokela R; Nuutinen L; Pelkonen O
Int J Cancer; 1987 May; 39(5):565-70. PubMed ID: 3570549
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of the mutagenic/carcinogenic action of cigarette smoke at the pulmonary level: enzymatic induction, activation and detoxification].
Scassellati Sforzolini G; Pasquini R; Savino A; Monarca S
Ann Ig; 1989; 1(1-2):295-311. PubMed ID: 2483074
[TBL] [Abstract][Full Text] [Related]
8. Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients.
Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Geneste O; Camoirano A; Saracci R; Giuntini C
Mutat Res; 1991; 250(1-2):103-14. PubMed ID: 1944327
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon hydroxylase activity in pulmonary alveolar macrophages and lymphocytes from lung cancer and noncancer patients: a correlation with family histories of cancer.
McLemore TL; Martin RR; Springer RR; Wray N; Cantrell ET; Busbee DL
Biochem Genet; 1979 Oct; 17(9-10):795-806. PubMed ID: 540021
[TBL] [Abstract][Full Text] [Related]
10. Environmental factors and aryl hydrocarbon hydroxylase activity (CYP1A1 phenotype) in human lymphocytes.
Kiyohara C; Hirohata T
J Epidemiol; 1997 Dec; 7(4):244-50. PubMed ID: 9465551
[TBL] [Abstract][Full Text] [Related]
11. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
[TBL] [Abstract][Full Text] [Related]
12. Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients.
Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Alexandrov K; Rojas M; Saracci R; Giuntini C
Environ Health Perspect; 1992 Nov; 98():119-24. PubMed ID: 1336722
[TBL] [Abstract][Full Text] [Related]
13. Suppression of aryl hydrocarbon hydroxylase activity in human primary lung carcinoma x mouse hepatoma somatic cell hybrids.
Manjunath GS; Dufresne MJ
Biochem Int; 1989 Aug; 19(2):413-20. PubMed ID: 2818604
[TBL] [Abstract][Full Text] [Related]
14. Population distribution of placental benzo(a)pyrene metabolism in smokers.
Gurtoo HL; Williams CJ; Gottlieb K; Mulhern AI; Caballes L; Vaught JB; Marinello AJ; Bansal SK
Int J Cancer; 1983 Jan; 31(1):29-37. PubMed ID: 6299972
[TBL] [Abstract][Full Text] [Related]
15. [A role of aryl hydrocarbon hydroxylase inducibility in susceptibility to lung carcinogenesis].
Kiyohara C; Hirohata T
Nihon Eiseigaku Zasshi; 1994 Feb; 48(6):1027-36. PubMed ID: 8126925
[TBL] [Abstract][Full Text] [Related]
16. Reassessment of the relationship between aryl hydrocarbon hydroxylase and lung cancer.
McLemore TL; Martin RR; Wray NP; Cantrell ET; Busbee DL
Cancer; 1981 Sep; 48(6):1438-43. PubMed ID: 7272966
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic activities of human lung tissue: relationship with smoking habits.
Pasquini R; Sforzolini GS; Cavaliere A; Savino A; Monarca S; Puccetti P; Fatigoni C; Antonini G
Carcinogenesis; 1988 Aug; 9(8):1411-6. PubMed ID: 3402037
[TBL] [Abstract][Full Text] [Related]
18. Some biotransformation enzymes responsible for polycyclic aromatic hydrocarbon metabolism in rat nasal turbinates: effects on enzyme activities of in vitro modifiers and intraperitoneal and inhalation exposure of rats to inducing agents.
Bond JA
Cancer Res; 1983 Oct; 43(10):4805-11. PubMed ID: 6309378
[TBL] [Abstract][Full Text] [Related]
19. Organ specificity of induction of activating and inactivating enzymes by cigarette smoke and cigarette smoke condensate.
Gielen JE; Goujon F; Sele J; Van Canfort J
Arch Toxicol Suppl; 1979; (2):239-51. PubMed ID: 288333
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer.
Ward E; Paigen B; Steenland K; Vincent R; Minowada J; Gurtoo HL; Sartori P; Havens MB
Int J Cancer; 1978 Oct; 22(4):384-9. PubMed ID: 212378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
